Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Growth

    Back to All Ratios
VALIANT LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) -40.72-96.81-

What is the latest Core EBITDA Growth ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Growth ratio of VALIANT LABORATORIES is -40.72 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-40.72
Mar2024-96.81
Mar2023-

How is Core EBITDA Growth of VALIANT LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -40.72
Negative
Mar2024 -96.81
0
Mar2023 0 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Growth ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹427.8 Cr 2.1% 25.6% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.4% 10.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 0.7% 9.5% 16.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr -2.5% 6% 36.2% Stock Analytics
CIPLA ₹115,641.0 Cr 9.7% 16.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 4.5% 9.7% 9% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

2.1%

25.6%

-11.6%

SENSEX

-2.7%

-2.1%

-5.3%


You may also like the below Video Courses